Enanta Pharmaceuticals
Develops oral RSV antivirals and immunology drugs funded by AbbVie HCV royalties.
$13.60
After-hours close−0.03 (−0.22%)
At close$13.63(−1.23%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.77 | — | — |
| Aug 2026 | −$0.51 | −$0.67 | −31.5% |
| May 2026 | −$0.46 | −$0.45 | +2.2% |
| Feb 2026 | −$0.54 | −$0.42 | +22.2% |
| Nov 2025 | −$1.13 | −$0.87 | +23.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | −$0.77 | — | — | $15.7M | — | — |
| Aug 10, 2026 | −$0.51 | −$0.67 | −31.5% | $16.8M | $14.4M | −14.3% |
| May 11, 2026 | −$0.46 | −$0.45 | +2.2% | $17.0M | $17.2M | +0.8% |
| Feb 9, 2026 | −$0.54 | −$0.42 | +22.2% | $15.9M | $18.6M | +17.0% |
| Nov 17, 2025 | −$1.13 | −$0.87 | +23.0% | $16.0M | $15.1M | −5.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 12, 2025 | ||||||
| Feb 10, 2025 | ||||||
| Nov 25, 2024 | ||||||
| Aug 5, 2024 | ||||||
| May 6, 2024 | ||||||
| Feb 7, 2024 | ||||||
| Nov 20, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 7, 2023 | ||||||
| Nov 21, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 8, 2022 | ||||||
| Nov 22, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Feb 8, 2021 | ||||||
| Nov 23, 2020 | ||||||
| Aug 4, 2020 | ||||||
| May 6, 2020 | ||||||
| Feb 6, 2020 | ||||||
| Nov 21, 2019 | ||||||
| Aug 6, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 6, 2019 | ||||||
| Nov 26, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 8, 2018 | ||||||
| Feb 7, 2018 | ||||||
| Nov 20, 2017 | ||||||
| Aug 7, 2017 | ||||||
| May 8, 2017 | ||||||
| Feb 8, 2017 | ||||||
| Nov 21, 2016 | ||||||
| Aug 8, 2016 | ||||||
| May 9, 2016 | ||||||
| Feb 8, 2016 | ||||||
| Nov 23, 2015 | ||||||
| Aug 6, 2015 | ||||||